(19)
(11) EP 1 824 846 A2

(12)

(88) Date of publication A3:
27.07.2006

(43) Date of publication:
29.08.2007 Bulletin 2007/35

(21) Application number: 05826439.1

(22) Date of filing: 30.11.2005
(51) International Patent Classification (IPC): 
C07D 417/06(2006.01)
A61K 31/425(2006.01)
C07D 403/06(2006.01)
A61P 25/28(2006.01)
(86) International application number:
PCT/EP2005/012765
(87) International publication number:
WO 2006/058720 (08.06.2006 Gazette 2006/23)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 02.12.2004 US 2169
24.05.2005 US 684137 P

(71) Applicant: Probiodrug AG
06120 Halle/Saale (DE)

(72) Inventors:
  • NIESTROJ, André, Johannes
    06193 Sennewitz (DE)
  • HEISER, Ulrich
    06108 Halle/Saale (DE)
  • SCHULZ, Ingo
    06120 Halle/Saale (DE)
  • RAHFELD, Jens-Ulrich
    06120 Lieskau (DE)
  • BÄR, Joachim
    06108 Halle/Saale (DE)
  • DEMUTH, Hans-Ulrich
    06114 Halle/Saale (DE)

(74) Representative: Hoffmann, Matthias 
Probiodrug AG Weinbergweg 22
06120 Halle/Saale
06120 Halle/Saale (DE)

   


(54) NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS